How to Mitigate Risk in the Treatment of Patients with Borderline Personality Disorder

被引:0
作者
Hersh, Richard G. [1 ]
机构
[1] Columbia Vagelos Coll Phys & Surg, 25 West 81st St, New York, NY 10024 USA
关键词
Malpractice; Borderline personality disorder; Evidence-based treatment; Risk management; Polypharmacy; BARRIERS;
D O I
10.1007/s11920-024-01558-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of ReviewClinicians treating patients with borderline personality disorder (BPD) experience concerns about risk for adverse events that can lead to litigation or complaints to administrative boards. This paper's goal is to outline steps to ensure the safety of both the patient and clinician.Recent FindingsReview of available data confirms that psychiatry is a subspeciality with relatively low risk for malpractice litigation, but high risk for complaints to administrative agencies. Examination of litigation and complaints suggests that familiar challenges in work with patients with BPD are frequently cited. Risk management considerations have been impacted in recent years by changes in psychiatric training, health care delivery, and regulations about patient information transparency. Concurrently, empirically validated treatments for BPD have been refined and disseminated.SummaryClinicians can address safety concerns by adapting established risk management guidance with an appreciation of key elements of BPD.
引用
收藏
页码:816 / 821
页数:6
相关论文
共 36 条
  • [1] AKISKAL HS, 1985, J CLIN PSYCHIAT, V46, P41
  • [2] Treatment utilization by patients with personality disorders
    Bender, DS
    Dolan, RT
    Skodol, AE
    Sanislow, CA
    Dyck, IR
    McGlashan, TH
    Shea, MT
    Zanarini, MC
    Oldham, JM
    Gunderson, JG
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (02) : 295 - 302
  • [3] What Works in the Treatment of Borderline Personality Disorder
    Choi-Kain L.W.
    Finch E.F.
    Masland S.R.
    Jenkins J.A.
    Unruh B.T.
    [J]. Current Behavioral Neuroscience Reports, 2017, 4 (1) : 21 - 30
  • [4] A pilot randomized controlled trial of ketamine in Borderline Personality Disorder
    Fineberg, Sarah K.
    Choi, Esther Y.
    Shapiro-Thompson, Rosa
    Dhaliwal, Khushwant
    Neustadter, Eli
    Sakheim, Madison
    Null, Kaylee
    Trujillo-Diaz, Daniel
    Rondeau, Jocelyne
    Pittaro, Giana F.
    Peters, Jessica R.
    Corlett, Philip R.
    Krystal, John H.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 (07) : 991 - 999
  • [5] Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review
    Fineberg, Sarah K.
    Gupta, Swapnil
    Leavitt, Jacob
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2019, 27 (02) : 75 - 86
  • [6] Borderline Personality Disorder: Ontogeny of a Diagnosis
    Gunderson, John G.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (05) : 530 - 539
  • [7] GUTHEIL TG, 1980, HOSP COMMUNITY PSYCH, V31, P479
  • [8] GUTHEIL TG, 1985, AM J PSYCHIAT, V142, P9
  • [9] GUTHEIL TG, 1989, AM J PSYCHIAT, V146, P597
  • [10] COMPLEX PTSD - A SYNDROME IN SURVIVORS OF PROLONGED AND REPEATED TRAUMA
    HERMAN, JL
    [J]. JOURNAL OF TRAUMATIC STRESS, 1992, 5 (03) : 377 - 391